James M. Hewitt

Array ( [id] => 11750290 [patent_doc_number] => 09708292 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-18 [patent_title] => 'Cyanopyrimidine derivative' [patent_app_type] => utility [patent_app_number] => 12/865472 [patent_app_country] => US [patent_app_date] => 2010-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17248 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12865472 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5972827 [patent_doc_number] => 20110152284 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'Sigma ligands for neuronal regeneration and functional recovery' [patent_app_type] => utility [patent_app_number] => 12/656182 [patent_app_country] => US [patent_app_date] => 2010-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 14985 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152284.pdf [firstpage_image] =>[orig_patent_app_number] => 12656182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573038 [patent_doc_number] => 20110268694 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'METHODS FOR TREATING VASCULAR LEAK SYNDROME' [patent_app_type] => utility [patent_app_number] => 12/677512 [patent_app_country] => US [patent_app_date] => 2010-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 56537 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268694.pdf [firstpage_image] =>[orig_patent_app_number] => 12677512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6321942 [patent_doc_number] => 20100113578 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Prevention of and countermeasures against mitochondrial disease' [patent_app_type] => utility [patent_app_number] => 12/654963 [patent_app_country] => US [patent_app_date] => 2010-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4183 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20100113578.pdf [firstpage_image] =>[orig_patent_app_number] => 12654963 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6628056 [patent_doc_number] => 20100172991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'Extended Release Formulation and Methods of Treating Adrenergic Dysregulation' [patent_app_type] => utility [patent_app_number] => 12/645772 [patent_app_country] => US [patent_app_date] => 2009-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 21496 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172991.pdf [firstpage_image] =>[orig_patent_app_number] => 12645772 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487617 [patent_doc_number] => 20110251180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'PHARMACEUTICAL AGENT COMPRISING QUINOLONE COMPOUND' [patent_app_type] => utility [patent_app_number] => 13/128803 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11449 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251180.pdf [firstpage_image] =>[orig_patent_app_number] => 13128803 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6373009 [patent_doc_number] => 20100080847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'MEDICINAL COMPOSITIONS QUICKLY DISINTEGRATING IN THE ORAL CAVITY AND PROCESS FOR PRODUCING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/631214 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7766 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080847.pdf [firstpage_image] =>[orig_patent_app_number] => 12631214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6537730 [patent_doc_number] => 20100204251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-12 [patent_title] => 'MOLECULAR TARGET OF NEUROTOXICITY' [patent_app_type] => utility [patent_app_number] => 12/628561 [patent_app_country] => US [patent_app_date] => 2009-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9244 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0204/20100204251.pdf [firstpage_image] =>[orig_patent_app_number] => 12628561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6447730 [patent_doc_number] => 20100144858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'Treatment of movement disorders with a metabotropic glutamate 4 receptor positive allosteric modulator' [patent_app_type] => utility [patent_app_number] => 12/592499 [patent_app_country] => US [patent_app_date] => 2009-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8228 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20100144858.pdf [firstpage_image] =>[orig_patent_app_number] => 12592499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6248886 [patent_doc_number] => 20100137271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS' [patent_app_type] => utility [patent_app_number] => 12/625284 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11677 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20100137271.pdf [firstpage_image] =>[orig_patent_app_number] => 12625284 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6246013 [patent_doc_number] => 20100136105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-03 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ADMINISTRATION OF HYDROPHOBIC DRUGS' [patent_app_type] => utility [patent_app_number] => 12/625309 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22148 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20100136105.pdf [firstpage_image] =>[orig_patent_app_number] => 12625309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6536344 [patent_doc_number] => 20100124550 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-20 [patent_title] => 'AMIDE INHIBITORS OF RENIN' [patent_app_type] => utility [patent_app_number] => 12/622933 [patent_app_country] => US [patent_app_date] => 2009-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19856 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20100124550.pdf [firstpage_image] =>[orig_patent_app_number] => 12622933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4486940 [patent_doc_number] => 07884122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-08 [patent_title] => 'Extended release formulation and method of treating adrenergic dysregulation' [patent_app_type] => utility [patent_app_number] => 12/615477 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 21 [patent_no_of_words] => 11381 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/884/07884122.pdf [firstpage_image] =>[orig_patent_app_number] => 12615477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7756942 [patent_doc_number] => 20120028985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'COMBINATIONAL THERAPY FOR TREATING AUTOIMMUNE DISEASE' [patent_app_type] => utility [patent_app_number] => 13/128213 [patent_app_country] => US [patent_app_date] => 2009-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14442 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20120028985.pdf [firstpage_image] =>[orig_patent_app_number] => 13128213 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223488 [patent_doc_number] => 20100056643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'CHEMICALLY INDUCED INTRACELLULAR HYPERTHERMIA' [patent_app_type] => utility [patent_app_number] => 12/613189 [patent_app_country] => US [patent_app_date] => 2009-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 34633 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056643.pdf [firstpage_image] =>[orig_patent_app_number] => 12613189 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8807823 [patent_doc_number] => 08445475 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-05-21 [patent_title] => 'Supramolecular complexes as photoactivated DNA cleavage agents' [patent_app_type] => utility [patent_app_number] => 12/610729 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 15560 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 139 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12610729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10838059 [patent_doc_number] => 08865733 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-21 [patent_title] => 'Medication and treatment for disease' [patent_app_type] => utility [patent_app_number] => 13/128177 [patent_app_country] => US [patent_app_date] => 2009-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2099 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13128177 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433367 [patent_doc_number] => 20100152295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-17 [patent_title] => 'METHODS OF REDUCING SMALL, DENSE LDL PARTICLES' [patent_app_type] => utility [patent_app_number] => 12/579996 [patent_app_country] => US [patent_app_date] => 2009-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16563 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20100152295.pdf [firstpage_image] =>[orig_patent_app_number] => 12579996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6016850 [patent_doc_number] => 20110224227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'HEMATOPOIETIC PROTECTION AGAINST CHEMOTHERAPEUTIC COMPOUNDS USING SELECTIVE CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/122061 [patent_app_country] => US [patent_app_date] => 2009-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 25478 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224227.pdf [firstpage_image] =>[orig_patent_app_number] => 13122061 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6545243 [patent_doc_number] => 20100016294 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'METHODS FOR REDUCING THE RISK OF AN ADVERSE DRUG INTERACTION IN A PATIENT SUFFERING FROM INSOMNIA' [patent_app_type] => utility [patent_app_number] => 12/567543 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6221 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20100016294.pdf [firstpage_image] =>[orig_patent_app_number] => 12567543 [rel_patent_id] =>[rel_patent_doc_number] =>)